| Bioactivity | NMS-P528 is a Duocarmycin derivative that can be used as an ADC payload. NMS-P528 can be used to synthesize NMS-P945[1]. |
| Name | NMS-P528 |
| CAS | 1466546-45-1 |
| Formula | C27H28ClN3O3S |
| Molar Mass | 510.05 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Barbara Valsasina, et al. Novel thienoduocarmycin-trastuzumab ADC demonstrates Strong Anti-tumor Efficacy with Favorable Safety Profile in Preclinical Studies. Mol Cancer Ther. 2023 Sep 19. |
NMS-P528
CAS: 1466546-45-1 F: C27H28ClN3O3S W: 510.05
NMS-P528 is a Duocarmycin derivative that can be used as an ADC payload. NMS-P528 can be used to synthesize NMS-P945.
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.